Gene-expression signature of tumor recurrence in patients with stage II and III colon cancer treated with 5fluoruracil-based adjuvant chemotherapy
International Journal of Cancer, 07/27/2012
Clinical Article
Giraldez MD et al. – Identification of a new gene–expression signature associated with a high probability of tumor recurrence in patients with stage II and III colon cancer receiving adjuvant 5'fluoruracil (5FU)–based chemotherapy, and its combination in a robust, easy–to–use and reliable algorithm may contribute to tailor treatment and surveillance strategies.



